Gender differences in outcome after stent treatment of lesions in the femoropopliteal segment

Scandinavian Journal of Surgery

Volumn 101, Issue 3, 2012, Pages 177-183

  Lindgren, Hans ^a,b   Gottsater A ^c   Hermansson, K ^b   Qvarfordt, P ^b   Bergman, S ^d  

^a LUND UNIVERSITY   (Sweden)

^b HELSINGBORG HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d Spenshult Hospital   (Sweden)

Author keywords

Amputation; Critical limb ischemia; Gender difference; Nitinol stent; Peripheral arterial disease; Superficial femoral artery

Indexed keywords

EID: 84867054594     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749691210100307     Document Type: Article

References (25)

1. norgren L, Hiatt WR, Dormandy JA, et al: tASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (II). J Vasc Surg. 2007;45 (1Suppl):S5-S67
2. Capek P, McLean gK, Berkowitz HD: Femoropopliteal angioplasty. Factors influencing long term success. Circulation. 1991;83(2suppl):170-180
3. Schillinger M, Sabeti S, Loewe C, et al: Ballon Angioplasty versus implantation of nitinol stents in the superficial femoral artery. n Engl J Med. 2006;354:1879-1888
4. AbuRahma AF, Hayes JD, Flaherty SK, et al: Primary iliac stenting versus transluminal angioplasty with selective stenting. J Vasc Surg. 2007;46:965-970
5. Cejna M, Thurnher S, Illiasch H, Horvath W et al: PtA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter preospective randomized study. J Vasc Interv Radiol. 2001;12:23-31
6. Henry M, Amor M, Beyar R, Henry, I et al: Clinical experience with a new nitinol selrexpanding stent in peripheral artery disease. J Endovasc Surg. 1996;3:369-379
7. Duda SH, Pusich B, Richter G, et al: Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: Six month results. Circulation. 2002;106:1505-1509
8. Duda SH, Bosiers M, Lammer J, Scheinert D, et al: Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the Sirocco II trial. J Vasc Interv Radiol. 2005;16:331-338
9. Scheinert D, Scheinert S, Sax J, et al: Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45:312-315
10. Schillinger M, Sabeti S, Dick P, et al: Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115: 2745-2749
11. Sabeti S, Czerwenka-Wenkstetten A, Dick P, et al: Quality of life after balloon angioplasty versus stent implantation in the superficial femoral artery: findings from a randomized controlled trial. J Endovasc ther. 2007;14:431-437
12. Sigvant B, Wiberg-Hedman K, Bergqvist D, et al: A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg. 2007;45:1185-1191
13. Sigvant B, Lundin F, nilsson B, et al: Intermittent claudication is the same disease in women and men but differs in presentation. thesis for doctoral degree (Phd) Karolinska Institute, Stockholm 2009
14. Nguyen L, Liles DR, Lin PH, et al: Hormone replacement therapy and peripheral vascular disease in women. Vasc Endovascular Surg. 2004;38:547-556
15. Conrad MF, Crawford RS, Hackney LA, et al: Endovascular management of patients with critical limb ischemia. Vasc Surg. 2011 Apr;53(4):1020-1025. Epub 2011 Jan 6.)
16. Swedvasc 2009: the Swedish national Registry for Vascular Surgery. (Yearly report in Swedish). Available at www.ucr.uu.se/swedvasc.
17. Kahn MU, Lall P, Harris LM et al: Predictors of limb loss despite a patent endovascular treated arterial segment (PEtAS). J Vasc Surg 2009;49:1440-1445
18. Barani J, Nilsson JA, Mattiasson I, et al: Inflammatory mediators are associated with 1-year mortality in critical limb ischemia. J Vasc Surg. 2005;42:75-80
19. Taneja M, tay KH, Dewan A, et al: Bare nitinol stent enabled recanalization of long-segment, chronic total occlusion of superficial femoral and adjacent proximal popliteal artery in diabetic patients presenting with critical limb ischemia. Cardiovasc Revasc Med. 2010;11:232-235
20. Ihnat DM, Duong ST, Taylor ZC, et al: Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of tASC classification and runoff score. J Vasc Surg. 2008;47:967-974
21. Gillgren P, Pettersson H, Fernström J, et al: Outcome after nitinol stenting in the superficial femoral and popliteal artery in an elderly population. Ann Vasc Surg. 2011 Mar 24. [Epub ahead of print]
22. Clarke KW, gray D, Keating nA, et al: Do women with acute myocardial infarction receive the same treatment as men? BMJ 1994;309:563-566
23. Johannesson A, Larsson gU, Ramstrand n, et al: Incidence of lower-limb amputation in the diabetic and nondiabetic general population A 10-year population-based cohort study of initial unilateral and contralateral amputations and reamputations. Diabetes Care. 2009;32: 275-280
24. Vouyouka Ag, Kent KC: Arterial vascular disease in women. J Vasc Surg. 2007;46:1295-302
25. Caes F, Cham B, Van den Brande P, et al: Small artery syndrome in women. Surg gynecol Obstet. 1985;161:165-170